Margo J. H. van Campenhout

Author

Also Known As

M.J. Van Campenhout, M.J. van Campenhout, M.J.H. van Campenhout, Margo J H van Campenhout, Margo J. H. van Campenhout, Margo J. van Campenhout, Margo J.H. van Campenhout

Publications

655

Citations

H-Index

Concepts

All Affiliations

Erasmus MC University Health Network University of Toronto Toronto General Hospital Istanbul University-Cerrahpaşa

About

Margo J. H. van Campenhout is an author at Erasmus MC specializing in immunology, medicine, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	126
2	Hepatology	5	5	126
3	Immunology	5	5	126
4	Public Health	1	1	22
5	Epidemiology	1	1	22

Margo J. H. van Campenhout

Publications

477

Citations

H-Index

Page 1

	Year	Citations
Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment Margo J. H. van Campenhout, Florian van Bömmel, Maria Pfefferkorn, Hepatology	2018	88
Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B Mina Farag, Margo J. H. van Campenhout, Maria Pfefferkorn, Clinical Infectious Diseases	2020	69
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B Kin Seng Liem, Margo J. H. van Campenhout, Qing Xie, Alimentary Pharmacology & Therapeutics	2019	31
Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection Hannah Choi, Margo J. H. van Campenhout, Anneke J. van Vuuren, Clinical Gastroenterology and Hepatology Viral PersistenceHepatologyViral HepatitisImmunologyHepatitis B	2020	30
Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients Margo J. H. van Campenhout, Willem Pieter Brouwer, Gertine W. van Oord, Clinical Microbiology and Infection Hepatic DisordersAutoimmune DiseaseHepatologyViral HepatitisImmunology	2016	28
CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation X.-L. Shi, E.L.D. de Mare‐Bredemeijer, Özlem Tapirdamaz, American Journal of Transplantation Transplant RejectionTransplantationHepatologySolid Organ TransplantationImmunology	2015	27
Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts A. J. Mueller, Fernando García-Alcalde, Steffen Wildum, Scientific Reports	2019	27
Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B Margo J. H. van Campenhout, Florian van Bömmel, Maria Pfefferkorn, Journal of Viral Hepatitis	2020	27
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss Sylvia M. Brakenhoff, Robert A. de Man, André Boonstra, Alimentary Pharmacology & Therapeutics	2020	24
Hepatitis B core‐related antigen monitoring during peginterferon alfa treatment for HBeAg‐negative chronic hepatitis B Margo J. H. van Campenhout, Vincent Rijckborst, Willem Pieter Brouwer, Journal of Viral Hepatitis ImmunologyHepatitis BAutoimmune Liver DiseaseViral HepatitisClinical Epidemiology	2019	22

Page 1